Stocks Overview

LAST PRICE
2.2900
TODAY'S CHANGE (%)
Trending Down-0.0600 (-2.5532%)

Bid / Lots
2.2900/ 4
Ask / Lots
2.3000/ 4
Open / Previous Close
2.3500 / 2.3500
Day Range
Low 2.2600
High 2.4000
52 Week Range
Low 1.3000
High 10.0900
Volume
181,965
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 2.35
Time	Volume	OMGA
09:32 ET	1077	2.35
09:34 ET	300	2.345
09:38 ET	100	2.33
09:39 ET	801	2.34
09:41 ET	936	2.36
09:43 ET	738	2.37
09:45 ET	986	2.38
09:50 ET	500	2.38
09:54 ET	200	2.38
09:57 ET	400	2.39
09:59 ET	681	2.39
10:01 ET	497	2.395
10:03 ET	200	2.395
10:08 ET	100	2.38
10:10 ET	1450	2.39
10:12 ET	100	2.38
10:14 ET	300	2.37
10:15 ET	1500	2.37
10:19 ET	250	2.34
10:21 ET	200	2.34
10:24 ET	200	2.34
10:26 ET	1481	2.335
10:28 ET	505	2.33
10:30 ET	1650	2.345
10:32 ET	100	2.34
10:33 ET	1020	2.35
10:35 ET	100	2.34
10:37 ET	500	2.35
10:39 ET	200	2.35
10:42 ET	200	2.34
10:44 ET	911	2.3358
10:46 ET	410	2.33
10:48 ET	1650	2.325
10:50 ET	500	2.3299
10:51 ET	2309	2.32
10:53 ET	400	2.325
10:55 ET	2599	2.315
10:57 ET	590	2.315
11:00 ET	200	2.31
11:02 ET	825	2.31
11:06 ET	300	2.31
11:08 ET	100	2.315
11:09 ET	100	2.31
11:11 ET	200	2.3
11:13 ET	1508	2.29
11:18 ET	230	2.29
11:20 ET	6100	2.28
11:22 ET	100	2.28
11:24 ET	400	2.285
11:26 ET	491	2.28
11:27 ET	200	2.28
11:29 ET	1271	2.28
11:31 ET	210	2.28
11:33 ET	264	2.28
11:36 ET	10306	2.26
11:38 ET	100	2.27
11:40 ET	600	2.275
11:42 ET	120	2.275
11:44 ET	590	2.275
11:47 ET	100	2.27
11:49 ET	200	2.275
11:51 ET	1547	2.285
11:56 ET	100	2.28
11:58 ET	140	2.285
12:02 ET	500	2.285
12:03 ET	280	2.285
12:05 ET	300	2.28
12:07 ET	100	2.285
12:12 ET	100	2.285
12:14 ET	490	2.285
12:16 ET	3032	2.3
12:23 ET	200	2.29
12:25 ET	11897	2.275
12:27 ET	5558	2.2712
12:30 ET	500	2.265
12:34 ET	1360	2.28
12:36 ET	400	2.27
12:38 ET	100	2.27
12:39 ET	550	2.275
12:41 ET	200	2.275
12:43 ET	100	2.275
12:45 ET	1593	2.26
12:48 ET	800	2.265
12:50 ET	400	2.26
12:52 ET	200	2.26
12:54 ET	400	2.26
12:56 ET	200	2.26
12:57 ET	500	2.265
12:59 ET	2558	2.285
01:01 ET	100	2.285
01:03 ET	366	2.28
01:06 ET	800	2.28
01:10 ET	1436	2.285
01:12 ET	200	2.285
01:14 ET	1270	2.295
01:15 ET	300	2.295
01:17 ET	100	2.29
01:19 ET	200	2.29
01:21 ET	5500	2.295
01:24 ET	13137	2.305
01:28 ET	110	2.3
01:30 ET	200	2.3
01:32 ET	9792	2.33
01:39 ET	400	2.32
01:42 ET	2100	2.31
01:44 ET	1291	2.3012
01:48 ET	300	2.31
01:50 ET	100	2.3
01:51 ET	300	2.31
01:53 ET	780	2.31
01:55 ET	1907	2.31
01:57 ET	2700	2.31
02:00 ET	3500	2.3001
02:02 ET	7971	2.3
02:04 ET	1900	2.2902
02:06 ET	200	2.29
02:09 ET	300	2.3
02:11 ET	100	2.29
02:13 ET	100	2.3
02:15 ET	1100	2.3
02:18 ET	3442	2.29
02:20 ET	400	2.29
02:24 ET	1613	2.29
02:26 ET	100	2.29

Data delayed at least 15 minutes.

Apr 23, 2024
- Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
  7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 16, 2024
- DJ Omega Therapeutics CFO Reed To Depart, from 5:05PM ET on Tuesday Apr 16, 2024 by Dow Jones
  5:05PM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 9, 2024
- Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control, from 7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
  7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 3, 2024
- DJ Omega Therapeutics Price Target Cut to $9.00/Share From $10.00 by Piper Sandler, from 11:38AM ET on Wednesday Apr 03, 2024 by Dow Jones
  11:38AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 1, 2024
- DJ Omega Therapeutics Is Maintained at Buy by Chardan Capital, from 8:34AM ET on Monday Apr 01, 2024 by Dow Jones
  8:34AM ET on Monday Apr 01, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesOMGA Omega Therapeutics Inc	129.6M	-1.3x	---
United StatesSGMT Sagimet Biosciences Inc	125.1M	-3.1x	---
United StatesVTGN Vistagen Therapeutics Inc	127.0M	-1.3x	---
United StatesTVGN Tevogen Bio Holdings Inc	131.5M	-2.3x	---
United StatesCOYA Coya Therapeutics Inc	123.1M	-10.2x	---
United StatesLPTX Leap Therapeutics Inc	121.3M	-0.6x	---
As of 2024-04-26

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in the development of a programmable epigenomic mRNA medicine to treat or cure a broad range of diseases. The Company’s OMEGA platform has enabled it to identify and validate various DNA-sequence-based epigenomic, zip codes, associated with individual regulatory elements within Insulated Genomic Domains (IGDs). The Company designs and engineers its mRNA therapeutics, called epigenomic controllers, or ECs, to target EpiZips for precision epigenomic control. Its pipeline consists of programs that span oncology, regenerative medicine, and multigenic diseases including immunologic and cardiometabolic conditions. The Company’s precision epigenomic control delivered by the OMEGA platform has therapeutic applicability and transformational potential, spanning across oncology, multigenic diseases including immunologic and cardiometabolic conditions, and regenerative medicine.

Contact Information

Headquarters: 140 First Street, Suite 501CAMBRIDGE, MA, United States 02141
Phone: 617-949-4360
Fax: 302-655-5049

Executives

Director: Christian Schade
President, Chief Executive Officer, Director: Mahesh Karande
Chief Financial Officer: Joshua Reed
Chief Human Resource Officer: Kevin McManus
Principal Financial Officer, Senior Vice President - Finance, Principal Accounting Officer: Barbara Chan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$129.6M
Revenue (TTM)	$3.1M
Shares Outstanding	55.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-1.81
Book Value	$1.05
P/E Ratio	-1.3x
Price/Sales (TTM)	41.9
Price/Cash Flow (TTM)	---
Operating Margin	-3,239.42%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Omega Therapeutics Inc
NASDAQ:OMGAUnited States

Search Criteria

Charts

Recent News

Apr 23, 2024

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones

Apr 16, 2024

DJ Omega Therapeutics CFO Reed To Depart, from 5:05PM ET on Tuesday Apr 16, 2024 by Dow Jones

Apr 9, 2024

Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control, from 7:00AM ET on Tuesday Apr 09, 2024 by Dow Jones

Apr 3, 2024

DJ Omega Therapeutics Price Target Cut to $9.00/Share From $10.00 by Piper Sandler, from 11:38AM ET on Wednesday Apr 03, 2024 by Dow Jones

Apr 1, 2024

DJ Omega Therapeutics Is Maintained at Buy by Chardan Capital, from 8:34AM ET on Monday Apr 01, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar